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Objective: The objective was to examine the efficacy of several treatment regimens in
improving wound healing of cutaneous sulfur mustard (HD) injuries. Methods: Wound
healing studies were conducted in weanling pigs. Superficial dermal HD injuries were
debrided at 48 hours postexposure using an erbium-doped yttrium aluminum garnet
(Er:YAG) laser, followed by application of a treatment adjunct. A variety of noninvasive
bioengineering methods were conducted during the postsurgical observation period to
examine the various cosmetic and functional aspects of the skin. Histopathology was
performed at the end of each study (14 or 21 days postsurgery). Results: As noted
clinically, reepithelialization was nearly complete by 7 days postsurgery for many of the
sites treated with petrolatum and scarlet red dressings. By 21 days, the skin elasticity of
the petrolatum-dressed sites was not significantly different from that of sham-exposed
skin.Upondressingremovalonpostsurgeryday4,theneoepidermisofallograft-andthin
film-dressed sites was partially removed, with resultant petechial hemorrhaging. Mean
pathology scores for hydrocolloid-dressed sites were significantly lower than those of
untreated HD-exposed sites on postsurgery day 14. Conclusions: Care must be taken
during bandage changes, and a nonadherent dressing that could be left in place for a
longer period of time (eg, 7 days) would be beneficial. The use of cultured epithelial
allograftmaterialmayhaveapotentialroleifgrownonacompletelynonadherentbacking
and left undisturbed for at least a week. Xeroform Petrolatum and Scarlet Red Ointment
dressings are effective and inexpensive treatment adjuncts for HD injuries.
The opinions or assertions contained herein are the private views of the authors and are not to be construed
as official or as reflecting the views of the Army or the Department of Defense. Research was conducted in
compliance with the Animal Welfare Act and other Federal statutes and regulations relating to animals and
experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory
Animals, National Research Council, 1996. The facility where this research was conducted is fully accredited
by the Association for Assessment and Accreditation of Laboratory Animal Care International.
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Significant cutaneous sulfur mustard (HD) injuries can take several months to heal,
necessitate lengthy hospitalizations, and result in significant cosmetic and/or functional
deficits.Therearecurrentlynostandardizedoroptimizedmethodsofcasualtymanagement.
Current treatment strategy consists of symptomatic management and is designed to relieve
symptoms,preventinfections,andpromotehealing.1–5 Newstrategiesareneededtoprovide
foroptimalandspeedywoundhealing.Theultimategoalistodeterminethemostefficacious
treatment regimen to be applied in the clinical management of HD casualties. The ideal
regimen should return damaged skin to optimal appearance and normal function in the
shortest time. Improved treatment will result in a better cosmetic and functional outcome
for the patient and will enable the casualty to return to normal activities sooner.
As with deep thermal burns, deep HD injuries will require very aggressive approaches
(eg,serialtangentialexcisionfollowedbyautologoussplit-thicknessskingrafting).6,7 While
pastHDwound-healingresearchinourlaboratoryhasconcentratedondeepinjuries,super-
ficial dermal (second degree) HD injuries may have greater clinical relevance on the battle-
field.Partial-thicknessinjurieswilllikelynotrequiresuchsurgicallyaggressiveapproaches.
Treatment strategies for improved healing of established partial-thickness cutaneous HD
injurieshaverecentlybeenformulated.8,9 Theapproachwearetakingistoperformadequate
debridementofpartial-thicknessinjuries,thentreatthelesionslikechroniccutaneousulcers
or partial-thickness thermal burns using contemporary medical approaches.8,9 Following
adequate wound debridement using an erbium-doped yttrium aluminum garnet (Er:YAG)
laser,oneormoretreatmentadjunctsareapplied.Examplesofadjunctsunderconsideration
are dressings, topical nutritional support, skin substitutes, keratinocyte sprays, and vacuum
assisted closure (VAC).8,9
We describehereseveraltreatmentefficacystudiesconductedinaweanlingpigmodel.
Similaritiesbetweenhumanandporcineskinmakethisspeciesanappropriateanimalmodel
for efficacy testing of candidate treatment regimens.8 In addition to the histopathology con-
ducted at the end of the 14- to 21-day wound healing studies, a variety of noninvasive
bioengineering methods were used throughout the healing period to assess treatment ef-
ficacy. Such methods included reflectance colorimetry to evaluate erythema, skin hue,
chroma, and lightness7,10–13; torsional ballistometry to evaluate the mechanical properties
of skin firmness and elasticity7; evaporimetry to examine transepidermal water loss as a
wayt oevaluate barrier function7,13; 2-dimensional high-frequency (20 MHz) ultrasound
to examine edema formation11 and scar tissue thickness; and image analysis to evaluate
wound contraction.6
MATERIALS AND METHODS
Animal model
Female Yorkshire crossbred pigs (weanlings), Sus scrofa,9to 12 kg, were used (Country
View Farms, Shanksville, Pa). Research was conducted in compliance with the Animal
Welfare Act and other Federal statutes and regulations relating to animals and experiments
involving animals and adhered to principles stated in the Guide for the Care and Use of
Laboratory Animals, National Research Council, 1996. The facility where this research
was conducted is fully accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International.
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Sulfur mustard exposure
Eighteen to 24 hours before agent exposure, the ventral abdominal skin was clipped with
an electric clipper, and then depilated as previously described.7 Four exposure sites were
demarcated on the ventral abdominal surface, and exposed to liquid sulfur mustard for 8
min to produce superficial dermal injuries. The exposure procedures used were the same
as those previously described to induce 3-cm-diameter HD injuries7;h owever, in place of
the tile floats a calibration weight (300 g) was placed on top of the rubber stopper and
manually held in place for the duration of the exposure to ensure even downward pressure
and complete contact of the wetted filter paper with the skin.
Debridement procedure
At48hourspostexposure,theanimalswereanesthetizedwithisofluraneandselectedlesions
were debrided to a depth of 300 or 400 µm with an Er:YAG laser (Sciton Profile Laser
Surgical System with Scanner, Sciton Inc, Palo Alto, Calif) then immediately covered with
one of several dressings tested. On each animal, one HD-exposed site was left untreated (ie,
no debridement), and the other 2 HD-exposed sites were debrided with the Er:YAG laser
and a dressing applied. The fourth experimental (sham-exposed) site served as a negative
control.
Dressings
The following sterile dressings were tested: Xeroform Petrolatum Dressing (Sherwood
Medical, St. Louis, Mo), Scarlet Red Ointment Dressing (Sherwood Medical, St. Louis,
Mo), frozen cultured epithelial porcine allograft (Living Skin Bank, SUNY—Stony
Brook, NY), Flexzan Foam Adhesive Dressing (Bertek Pharmaceuticals Inc, Mor-
gantown, WVa), and DuoDERM Signal hydrocolloid dressing (ConvaTec, Princeton,
NJ).
Xeroform Petrolatum Dressing and Scarlet Red Ointment Dressing were tested side
by side in one wound healing study. Four pigs were used, with a 21-day healing period
following surgery. Lesions were debrided to a depth of 400 µmi nmultiple passes of the
laser. One laser-debrided site on each pig was dressed with Xeroform, and the other with
Scarlet Red. These dressings were secured over the laser-debrided wounds using surgical
staples. A pressure dressing was then applied using Kerlix Super Sponges (Tyco Healthcare
Group LP, Mansfield, Mass), Reston Self-Adhering Foam Pads (3M HealthCare, St Paul,
Minn), and elastic tape. The positive (+) control site (HD-exposed, not treated) and sham-
exposed site (negative control, with no HD exposure) were not dressed. A 20-cm-wide
tubular cotton stockinette (Abco Dealers Inc, Milwaukee, Wisc) was then stapled in place
over the animal’s entire torso to protect the dressings from becoming soiled. On the sixth
day following surgery, these dressings were removed and replaced with Telfa Plus Barrier
IslandDressings(KendallHealthcareProductsCompany,Mansfield,Mass)andelastictape,
whichwerekeptinplaceforoneadditionalday.Sitesremainedundressedfortheremainder
of the experiment.
Frozen cultured epithelial porcine allograft and Flexzan Foam Adhesive Dressing
were tested side-by-side in a second wound healing study. Six pigs were utilized, with a
14-day healing period following surgery. Lesions were debrided to a depth of 400 µmi n
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multiple passes of the laser. One laser-debrided site on each pig was dressed with allograft,
and the other with Flexzan. The cultured porcine allograft material was grown from pig
keratinocytes collected from weanling pigs procured from the same vendor as the one that
suppliedpigsfortheseefficacystudies.EpidermiswasseparatedfromdermisusingDispase
II (Roche Diagnostics GmbH, Mannheim, Germany).14 Keratinocytes were then harvested
and serially cultured with lethally irradiated 3T3-J2 feeder cells as previously described15
with minor modifications.16 Allografts were then prepared on a petrolatum gauze backing
and stored at −70◦C according to the procedures of Tamariz et al.17 Keratinocyte isolation
andallograftproductionwascarriedoutattheStateUniversityofNewYork,StonyBrook.A
frozen sheet of cultured porcine allograft was thawed to room temperature, placed over one
laser-debrided HD-exposed wound, covered with a single layer of Xeroform gauze, and a
pressuredressingputinplaceusingKerlixSuperSponges,RestonSelf-AdheringFoampads,
and elastic tape. A single 4   × 4   sheet of Flexzan was placed over another laser-debrided
HD-exposed site and covered with sterile gauze. The + control site and sham site were
covered with sterile gauze, secured in place by surgical staples. A tubular stockinette was
then stapled in place over the animal’s entire torso to protect the dressings from becoming
soiled. On the fourth day following surgery, all dressings were carefully removed and
additional (new) dressings put in place over the sites dressed with allograft or Flexzan. On
the sixth day following surgery, these dressings were removed and replaced with Telfa Plus
Barrier Island Dressings (Kendall Healthcare Products Company, Mansfield, Mass) and
elastic tape, which were kept in place for one additional day. Sites remained undressed for
the remainder of the experiment.
DuoDERM Signal dressings were tested in a third wound healing study that involved
2 different depths of laser debridement (300 and 400 µm). Six pigs were utilized, with
a 14-day healing period following surgery. One HD-exposed site on each animal was
debrided with the Er:YAG laser to a depth of 400 µmi nmultiple passes. A second
HD-exposedsitehad300µmoftissueremovedinmultiplepassesofthelaser.Bothdebrided
sites (designated as DuoDERM-300 and DuoDERM-400) were dressed with DuoDERM
Signal. While these dressings have an adhesive border, the edges of dressings were fur-
ther secured with surgical tape (Durapore), stapled on the corners. The + control site
and sham site were covered with sterile gauze (stapled in place with edges further se-
cured with Durapore tape). A tubular stockinette was then stapled in place over the ani-
mal’s entire torso to protect the dressings from becoming soiled. Dressings were removed
on the seventh day following surgery. Sites remained undressed for the remainder of the
experiment.
A summary flowchart for each experiment is presented below.
Time of surgery Debridement 2nd dressing Postsurgery (PS)
EXPERIMENT∗ (postexposure) depth (µm) application day for pathology
Xeroform/Scarlet Red 48 h 400 NO 21
Allograft/Flexzan 48 h 400 Yes (PS04) 14
DuoDERM-300/400 48 h 300 or 400 No 14
∗Each animal had 4 experimental sites: 1 sham-exposed site (−control), 1 HD-exposed and untreated site (+ control), and 2
HD-exposed and treated sites. Sites were rotated on the ventral abdominal surface to preclude sensitivity biases based upon
anatomical location. Treated sites were laser-debrided to the specified depth, and the dressings applied. All dressings were
removed 7 days after surgery. Noninvasive bioengineering measurements were conducted before HD exposure and weekly
after surgery until euthanasia.
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Postsurgical procedures
Noninvasive bioengineering methods
Av arietyofnoninvasivebioengineeringmethodswereusedtofollowtheprogressofwound
healing. Measurements included reflectance colorimetry (RC) to measure erythema, skin
hue, chroma, and lightness; evaporimetry to examine transepidermal water loss (TEWL)
as a method of evaluating barrier function; torsional ballistometry (TB) to evaluate the
mechanical properties of skin firmness and elasticity; and 2-dimensional high-frequency
(20 MHz) ultrasonography (HFU) to monitor skin thickness. Measurements were made
before agent exposure and on postsurgery days 7 (PS07; all studies), 14 (PS14; all studies),
and 21 (PS21; Xeroform/Scarlet Red study only) for all methods except HFU, which was
onlyconductedbeforeexposureandonthelastdayofeachstudy(PS14orPS21).Torsional
ballistometry was not conducted on PS07 in the DuoDERM study, to avoid disruption
of the fragile neoepidermis. HFU was not conducted in the DuoDERM study because of
equipment failure. Bioengineering methods were performed as previously described.7
Digital photography
Digital pictures of gross lesions were taken using a Kodak Professional DCS 315 digital
camera (Eastman Kodak Company, Rochester, NY). Images were used to assess wound
contractionbyimageanalysisonPS07(allstudies),PS14(allstudies),andPS21(Xeroform/
Scarlet Red study only).
Pathology
On the last day of each study, animals were euthanized with an overdose of pentobarbital
sodium (Fatal-Plus Solution, Vortech Pharmaceuticals Ltd, Dearborn, Mich; 78 mg/kg i.v.).
Full-thicknessexcisions(includingpanniculuscarnosa)ofeachentirelesionplussurround-
ing skin were removed, stapled onto labeled, laminated index cards, and placed into 10%
neutral buffered formalin. Sections were later trimmed, paraffin embedded, cut on a micro-
tome into 5-µm-thick sections, and stained with hematoxylin and eosin (H&E) for routine
histopathology. Serial sections were also stained with Masson’s trichrome to highlight der-
mal collagen, and Movat’s pentachrome to highlight elastic fibers. A veterinary pathologist
scored the sections in a blinded fashion based on a published histomorphologic scale for
ratingburnscars18 modifiedforevaluationofthetissues.Thefollowingscoringsystemwas
used (highest number represented normalcy): reepithelialization (1 = complete, 0 = not
complete), epidermal hyperplasia (1 = absent, 0 = present), epidermal-dermal separation
(1 = absent, 0 = present), inflammatory cells (1 = absent, 0 = present), hair follicles
(1 = present, 0 = absent), glands (1 = present, 0 = absent), elastic fibers (1 = normal, 0 =
reduced size and number), smooth muscles (1 = present, 0 = absent), collagen orientation
(3 = normal, 2 = abnormal papillary, 1 = abnormal upper reticular, 0 = abnormal lower
reticular), fibroplasia (1 = absent, 0 = present), vascular proliferation (1 = absent, 0 =
present), and hemorrhage (1 = absent, 0 = present). Maximum total score for best possible
outcome (eg, normalcy) was 14.
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Statistics
Xeroform/Scarlet Red study
For the bioengineering data, comparison of the experimental groups (sham controls, +
controls,andtreatedgroups)anddaysofobservationweremadeforeachmeasurementusing
a3-factormixed-modelanalysisofvariance(ANOVA)usingSPSS13.0forWindows(SPSS
Inc,Chicago,Ill).The2fixedfactorswereexperimentalgroupsanddaysofobservation.The
random factor was pig number. If a significant experimental group by day interaction was
observed, a 2-factor mixed-model ANOVA was used at each day to compare experimental
groups. The fixed factor was experimental groups and the random factor was pig number.
Pathology data were compared between experimental groups using a Chi-square test on
the frequencies of presence/absence and other categorical scores, followed by either a Chi-
square or Fisher exact test to compare pairs of experimental groups. A one-factor ANOVA
followed by a Tukey test was used to compare the mean total score parameter between
experimental groups. Statistical significance was defined as p <. 05 for all tests.
Allograft/Flexzan and DuoDERM studies
For the bioengineering data, sites were compared statistically using a one-factor ANOVA
at each day within each experimental group to compare responses between sites. A 2-factor
repeated-measures ANOVA with repeated measurements on both factors, day and experi-
mental group, was used to compare the measurements made on the exposure sites for each
experimental group. If a significant treatment by day interaction was observed, then a ran-
domizedblockANOVAateachdaywasusedtocomparetheexperimentalgroups.Pathology
datawascomparedbetweenexperimentalgroupsusingaChi-squaretestonthefrequencies
of presence/absence, followed by either a Chi-square or Fisher exact test to compare pairs
of experimental groups. ANOVA and t tests were used for the total score parameter.
RESULTS
Xeroform/Scarlet Red study
Mean animal weight on the day of exposure was 8.8 kg. Mean weight at the end of the study
(PS21) was 10.8 kg.
Transepidermal water loss
Nosignificanttreatmentgroupdifferenceswerenotedbeforeexposure(Fig1).Bioengineer-
ing data indicated barrier function was significantly disrupted for all HD-exposed groups
at PS07 and PS14. At PS07 and PS14, the mean TEWL rate for the sham group was sig-
nificantly less than for all other treatment groups, and the mean TEWL rate for the +
control group was significantly less than for the Xeroform group. Barrier function of all
HD-exposed groups had improved and was approaching normal limits of transepidermal
water loss by PS21. For the sham group, the mean TEWL rate was significantly lower at
PS21 than for all other groups, and the + control group had significantly higher water loss
rates than did the sites treated with Xeroform or Scarlet Red.
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Figure 1. Transepidermal water loss (TEWL) rates from the Xero-
form/Scarlet Red study. Barrier function was significantly disrupted for all
HD-exposed groups on PS07 and PS14. By PS21, barrier function of all HD-
exposedgroupshadimprovedandwasapproachingnormallimitsoftransepi-
dermalwaterloss.AtPS21,the+controlgrouphadsignificantlyhigherwater
loss rates than did the sites dressed with Xeroform or Scarlet Red.
Figure 2. Torsionalballistometrymeasurementsforskinhardnessfromthe
Xeroform/Scarlet Red study. On PS07 and PS21, indentation of the sham-
exposed (– control) group was significantly greater than the other groups,
indicating softer skin.
Reﬂectance colorimetry
Reflectance colorimetry could not be adequately evaluated because the red ointment from
the Scarlet Red dressing stained the skin. Data are not shown.
Torsional ballistometry
For the torsional ballistometry parameters, the + control group had 2 outliers on PS14,
which affected data analysis; therefore, PS14 data were excluded. For mean indentation
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Figure 3. Torsional ballistometry measurements for skin elasticity from the
Xeroform/Scarlet Red study. On PS21, the α values for the untreated positive
control and Scarlet Red groups were significantly greater than for the sham
group, indicating less elasticity. Skin elasticity of the Xeroform-treated sites
was not significantly different from that of the sham-exposed skin (– controls).
values (Fig 2), a significant day by treatment group interaction was noted. No significant
differences were noted before exposure. On PS07 and PS21, indentation of the sham group
was significantly greater than the other groups, indicating softer skin. No significant differ-
ences in mean α measurements (Fig 3) were noted before exposure or on PS07. On PS21,
the mean α values for + control and the Scarlet Red groups were significantly greater than
for the sham group, indicating less elasticity. Skin elasticity of the Xeroform-treated sites
was not significantly different from that of sham-exposed skin.
High-frequency ultrasonography
Nosignificantdifferenceswereobservedinskinthicknessbetweentreatmentgroupsbefore
exposure (Fig 4). At PS21, the sham-exposed group was significantly less thick than the +
control, Xeroform and Scarlet Red groups. Mean thickness of the Scarlet Red group was
significantly less than the + control and Xeroform groups.
Wound contraction
No apparent wound contraction was noted after wound debridement in any experimental
group (data not shown).
Pathology
BoththeXeroform-andScarletRed–treatedsiteshadgrosslyreepithelializedbetweenPS07
and PS14, whereas the untreated HD-exposed sites had a thin dry eschar present on PS14
which was just beginning to separate from the underlying, regenerating epithelium (Figs 5a
and 5b). No signs of infection were noted. Small spider veins were noted along portions of
the periphery of several of the debrided sites that were dressed with Scarlet Red (Fig 5b).
Histopathologyindicatedthatforepidermalhyperplasia,elasticfibers,collagenorientation,
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Figure 4. High frequency ultrasound measurements for skin thickness from
the Xeroform/Scarlet Red study. At PS21, skin from the sham-exposed
(–control)groupwassignificantlylessthickthantheskinfromallothergroups.
MeanthicknessoftheScarletRedgroupwassignificantlylessthanthe+control
and Xeroform groups.
fibroplasias, vascular proliferation, and hemorrhage, the sham group had significantly dif-
ferentdistributionsofresponsesfromthe+controlgroup(datanotshown).Forhyperplasia,
elastic fibers, and fibroplasias, the sham group had significantly different distributions of
responses from the Xeroform group. No other significant differences were observed. For
total score (Fig 6), the + control, Scarlet Red, and Xeroform groups had significantly lower
mean scores than the sham group. The Xeroform- and Scarlet Red–dressed sites had higher
meantotalscoresthanthe+controlsites(highscoreof14=normalcy);however,statistical
significance was not achieved. No other significant differences were observed.
Allograft/Flexzan study
Mean animal weight on the day of exposure was 10.5 kg. Mean weight at the end of the
study (PS14) was 14.9 kg.
Transepidermal water loss
No significant differences in transepidermal water loss rates were noted before exposurej
(Fig 7). For PS07 and PS14, the sham sites had significantly lower TEWL rates than the
+ control, allograft, and Flexzan sites. Also, for PS07 and PS14, the + control sites had
significantly lower TEWL rates than the allograft and Flexzan sites. TEWL rates for all
HD-exposed groups decreased between PS07 and PS14.
Reﬂectance colorimetry
Significant differences among treatment groups were observed for L* on PS07, a* on PS07
and PS14, delta a* on PS07 and PS14, b* on PS07 and PS14, delta b* on PS07, C* on PS07
and PS14, and delta C* on PS07 (data not shown). In general, by PS14 the HD-exposed
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sites (treated and untreated) were more erythematous than the sham sites and were not
significantly different in overall color change (delta E*ab) from each other.
Torsional ballistometry
No significant differences in hardness or elasticity were noted before exposure (Figs 8
and 9). On PS07, the sham-exposed control was significantly softer than each of the other
experimental groups, and the + control group was significantly harder than the allograft
andFlexzangroups.The+controlgroupwassignificantlylesselasticthantheshamgroup.
On PS14, sites from the sham-exposed group were significantly softer than those in each
of the other experimental groups. There were no differences in elasticity noted on PS14.
High-frequency ultrasonography
No significant differences in skin thickness were noted before exposure (Fig 10). On PS14,
the sham sites were significantly less thick than the + control, allograft, and Flexzan sites.
Figure 5. Clinical pictures on PS07, PS14, and PS21from the Xeroform/Scarlet Red study.
(a) The Xeroform sites had grossly reepithelialized between PS07and PS14, whereas the
untreated (NT) HD-exposed sites had a thin dry eschar present on PS14 that was just
beginning to separate from the underlying, regenerating epithelium. (b) The Scarlet Red
sites had grossly reepithelialized between PS07 and PS14, whereas the untreated (NT) HD-
exposed sites had a thin dry eschar present on PS14 that was just beginning to separate from
the underlying, regenerating epithelium. Small spider veins were noted along portions of
the periphery of several of the Scarlet Red–dressed sites.
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Figure 5. Continued
Figure 6. Total pathology scores from the Xeroform/Scarlet Red study.
TheXeroform-andScarletRed–dressedsiteshadhighermeantotalscores
than did the + control (untreated) sites; however, statistical significance
was not achieved.
Wound contraction
No apparent wound contraction was noted after wound debridement in any experimental
group (data not shown).
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Figure 7. Transepidermal water loss (TEWL) rates from the allograft/Flexzan
study. For PS07 and PS14, the sham-exposed (– control) sites had significantly
lower TEWL rates than the + control, allograft, and Flexzan sites. Also, for
PS07 and PS14, the + control sites had significantly lower TEWL rates than the
allograft and Flexzan sites. TEWL rates for all HD-exposed groups decreased
between PS07 and PS14.
Figure 8. Torsional ballistometry measurements for skin hardness from the
allograft/Flexzan study. By PS14, sites from the sham-exposed (– control)
group were significantly softer than those in each of the other experimental
groups.
Pathology
Typical gross lesions can be seen in Figs 11a and 11b. Upon dressing removal on PS04,
the neoepidermis of the allograft and Flexzan sites was partially removed, with resultant
petechial hemorrhaging. No signs of infection were noted. The sham-exposed sites had
significantly different distributions of responses for hyperplasia, collagen orientation, and
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Figure 9. Torsional ballistometry measurements for skin elasticity from the
allograft/Flexzanstudy.TherewerenodifferencesinelasticitynotedonPS14.
Figure 10. High frequency ultrasound measurements for skin thickness from
the allograft/Flexzan study. On PS14, the sham-exposed (– control) sites were
significantly less thick than the + control, allograft, and Flexzan sites.
vascular proliferation than did the allograft and Flexzan sites (data not shown). The sham
sites also had a significantly different distribution of responses for fibroplasias than did
the Flexzan sites. No other significant differences were observed. For total score (Fig 12),
the allograft and Flexzan sites had significantly lower mean scores than the sham sites. No
significant differences were observed between the + controls and the shams, allograft sites,
and Flexzan sites.
DuoDERM Signal study
Mean animal weight on the day of exposure was 12.3 kg. Mean weight at the end of the
study (PS14) was 17.8 kg.
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Transepidermal water loss
No significant differences in transepidermal water loss rates were noted before exposure
(Fig 13). For PS07 and PS14, the sham sites had significantly lower TEWL rates than the +
control,DuoDERM-300,andDuoDERM-400sites.Also,forPS07andPS14,the+control
siteshadsignificantlylowerTEWLratesthantheDuoDERM-300andDuoDERM-400sites.
TEWL rates in all HD-exposed groups decreased between PS07 and PS14, indicating that
barrier repair processes were underway.
Reﬂectance colorimetry
Significant differences among treatment groups were observed for L* on PS07 and PS14,
a* on PS07 and PS14, delta a* on PS07, b* on PS07, delta b* on PS07, and C* on PS07 and
PS14 (data not shown). In general, by PS14 the + control sites were darker than the others,
and all HD-exposed sites (treated and untreated) were more erythematous than were the
sham sites. The HD-exposed sites (treated and untreated) were not significantly different
in overall color change (delta E*ab) from each other.
Figure 11. Clinical pictures on PS04, PS07, and PS14 from the allograft/Flexzan study.
(a) Upon dressing removal on PS04, the neoepidermis of the allograft-dressed sites was
partially removed, with resultant petechial hemorrhaging. (b) Upon dressing removal on
PS04, the neoepidermis of the Flexzan-dressed sites was partially removed, with resultant
petechial hemorrhaging.
56GRAHAM ET AL
Figure 11. Continued
Figure 12. Total pathology scores from the allograft/Flexzan study. The
allograft and Flexzan sites had significantly lower mean scores than the
sham-exposed (– control) sites. No significant differences were observed
between the + controls and the shams, allograft sites, and Flexzan sites.
Torsional ballistometry
No significant differences in hardness or elasticity were noted before exposure (Figs 14
and 15). Because of the frailty to the neoepidermis after dressings are removed, these
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Figure 13. Transepidermal water loss (TEWL) rates from the DuoDERM
study. For PS07 and PS14, the sham-exposed (– control) sites had significantly
lower TEWL rates than the other sites. At these time points, the + control sites
had significantly lower TEWL rates than the DuoDERM-300 and DuoDERM-
400 sites. TEWL rates in all HD-exposed groups decreased between PS07 and
PS14, indicating that barrier repair processes were underway.
Figure 14. Torsional ballistometry measurements for skin hardness from the
DuoDERM study. On PS14 the sham-exposed (– control) sites were signifi-
cantly softer than those from the other experimental groups.
measurements were not conducted on PS07. On PS14, the sham sites were significantly
softer than those from the other experimental groups. Sites from the sham-exposed group
were more elastic than were sites from the + control and DuoDERM-400 groups.
High-frequency ultrasonography
Ultrasound measurements for skin thickness were not conducted because of equipment
failure.
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Figure 15. Torsional ballistometry measurements for skin elasticity from the
DuoDERM study. On PS14, sites from the sham-exposed (– control) group
were more elastic than were sites from the + control and DuoDERM-400
groups.
Wound contraction
No apparent wound contraction was noted after wound debridement in any experimental
group (data not shown).
Pathology
Typical gross lesions can be seen in Fig 16. Adhered elastic material (possibly hydrocolloid
from the dressing) can be seen over the DuoDERM-300 and DuoDERM-400 sites. No
signs of infection were noted. The sham sites had a significantly different distribution of
responses for hyperplasia and inflammatory cells than did the + controls, DuoDERM-
300 sites, and DuoDERM-400 sites (data not shown). The sham sites had a significantly
different distribution of responses for elastic fibers, collagen orientation, fibroplasias, and
vascular proliferation than did the DuoDERM-300 and DuoDERM-400 sites. The sham
sites had a significantly different distribution of response for hemorrhage than did the +
control sites. The + control sites had a significantly different distribution of responses for
elastic fibers than did the DuoDERM-400 sites, and a significantly different distribution of
responses for collagen orientation and vascular proliferation than did the DuoDERM-300
and DuoDERM-400 sites. For total scores (Fig 17), the + controls, DuoDERM-300 sites,
andDuoDERM-400siteshadsignificantlylowermeanscoresthantheshamsites,andthe+
controlshadasignificantlyhighermeanscorethantheDuoDERM-300andDuoDERM-400
sites.
DISCUSSION
Several sterile dressings were tested for efficacy in improving wound healing of cutaneous
HD injuries following laser debridement. Xeroform is a petrolatum-based dressing that is
commonly used in thermal burns management. Scarlet Red is a dressing that is sometimes
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Figure 16. ClinicalpicturesonPS07andPS14fromtheDuoDERMstudy.Adheredelastic
material (possibly hydrocolloid from the dressing) can be seen over the DuoDERM-treated
sites on PS07.
Figure 17. Total pathology scores from the DuoDERM study. The + controls,
DuoDERM-300,andDuoDERM-400siteshadsignificantlylowermeanscores
than the sham-exposed (– control) sites, and the + controls had a significantly
higher mean score than the DuoDERM-300 and DuoDERM-400 sites.
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used to dress split-thickness skin graft donor sites, providing speedy reepithelialization of
donor sites for subsequent harvesting of additional graft material. Flexzan is a sterile, ultra-
thin, highly comfortable, semiocclusive polyurethane foam adhesive dressing that protects
wounds from contamination and trauma while maintaining a moist wound healing environ-
ment. It is constructed of an open-cell foam with a closed-cell outer surface. Excess wound
moisture is absorbed into the cells of the foam and allowed to evaporate through the outer
surface, helping prevent fluid accumulation under the dressing. This dressing is frequently
used following laser facial resurfacing. DuoDERM Signal is a tapered-edge hydrocolloid
dressingthatprovidesamoistwoundhealingenvironmentandabsorbswoundexudate.The
dressing has a change indicator that “signals” the healthcare provider that enough wound
exudate has been absorbed to require a dressing change. Cultured epithelial allografts and
autografts have been used for about 2 decades as a treatment for chronic ulcers and thermal
burns.19−25 Keratinocytes can be harvested from skin biopsies and grown to confluence
by the method originally described by Rheinwald and Green.15 Large amounts of strati-
fying epidermis can thus be grown in the laboratory in short periods of time and used to
restore defects in the epidermis.26 Such grafts can be used immediately or cryopreserved
and used at a later date. In addition to their usefulness in improving the healing of deep
ulcers and burns, they have shown efficacy in improving the rate of reepithelialization of
partial-thickness burns20,22,24 and split-thickness skin graft donor sites.21,23,25 There is no
evidence that cultured allografts survive permanently on the wound bed.21 Kaawach et al20
showed that allografted cells were not present between 8 and 100 days postgrafting and
suggested that the newly formed epithelium was of host origin. Cultured keratinocyte al-
lografts speed healing by providing cover and producing growth factors and extracellular
matrix proteins.23 Because these coverings can be produced in large quantities and would
thus be more readily available than cadaver skin, their application in the treatment of de-
brided partial-thickness HD injuries should be considered. Cultured epidermal autografts
(CEA) would be safer to use, from the perspective of disease transmission, and would not
require donor screening procedures. They do, however, require small punch biopsies to be
collectedfromthepatientandalagtimeofabout2weekstogrowthegraftmaterial.Despite
their theoretical usefulness, CEA are rather limited in their clinical effectiveness because
they are unable to withstand even very low levels of bacterial wound contamination and do
not provide a durable epithelial surface. Wounds covered by this modality are unstable and
are subject to frequent epithelial disruption as a result of minor mechanical trauma. Dura-
bilityhasbeenincreasedbyplacingtheCEAonascaffoldingofwidelymeshedautograft.27
Alternatively,CEAplacedoverdeepithelializedallograft(ie,engraftedallodermis)hasalso
proved successful.28
In general, all HD-exposed sites (treated and untreated) had reepithelialized by PS14.
Reepithelialization was nearly complete by PS07 for many of the sites treated with Xero-
formandScarletRed.Thepressuredressingappliedoverthese2dressingsmayhaveplayed
a role in these improved results by keeping the dressings in very firm contact with the pre-
pared (laser-debrided) beds and reducing edema. In comparison, on PS14 the untreated HD
lesions often had a hardened eschar that was just beginning to separate from the underlying,
regenerating epithelium. Small spider veins were noted along portions of the periphery of
several of the debrided sites that were dressed with Scarlet Red. While these small surface
veinsarenotcosmeticallydesirable,theycouldberemovedwithfurtherlasertreatments(eg,
via pulsed dye lasers29). It was noted that upon bandage changes on PS04 in the allograft/
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Flexzan experiment, some of the neoepidermis had adhered to the dressings and was re-
moved with the dressings. Within the first week of surgery, the neoepidermis appears to be
very fragile and easily removed. Care must be taken during bandage changes, and a non-
adherent dressing that could be left in place for a longer period of time (eg, 7 days) would
be beneficial, both to the patient and medical logistical burden (eg, nursing care). Several
Flexzan-dressed sites were also noted to have a small accumulation of exudate built up
underneath the dressing. This dressing was thus not able to adequately manage the exudate.
The DuoDERM study showed that the amount of exudate produced by these laser-debrided
lesions was greater than anticipated, as witnessed by the amount of fluid absorbed into the
hydrocolloid dressing. The amount of exudate was moderate and the DuoDERM dressing
wasa blet ostay in place for 7 days without requiring a change.
In general, total histopathology scores of the treated sites were not substantially higher
than those of the + control sites. Epidermal hyperplasia, collagen remodeling, fibroplasia,
and vascular proliferation (neovascularization) were noted in all HD-exposed sites (treated
anduntreated).Thesearenormalprocessesseeninwoundhealing,30−34 andassuchitisnot
surprisingthatthesefindingswerenotedinthetissuescollectedonPS14orPS21.Excessive
scar tissue formation, which one would only expect to see following deep cutaneous burns
that are not excised and grafted, was not observed. In time, these normal physiological
responses to tissue injury are expected to subside, resulting in near-normal architecture.
Additional studies of a longer duration are needed to judge long-term outcome. While
there seemed to be few improvements in histological architecture 14 to 21days following
treatment, the reepithelialization process was sped up in many of the Xeroform- and Scarlet
Red–treated sites. Also, by the end of the study, skin elasticity of the Xeroform-treated
sites was not significantly different from that of sham-exposed skin. If an early dressing
change had not been performed in the allograft/Flexzan study (PS04), one may have also
seen improved results in that study.
Ingeneral,thetreatedwoundsweremildlyharderandequallyorslightlylesselasticthan
normalskinby14to21dayspostsurgery.WhileHD-exposedskinsectionswerestatistically
thickerthannormalskin,noclinicallysignificantamountsofscartissuehadformed,asseen
by histology. In contrast, deep HD injury has been noted to induce relatively thick, hard,
and inelastic scar tissue in pigs.6,7
By the end of each study, the HD-exposed sites (treated and untreated) were mildly
erythematous and similar in color to each other. Erythema is a normal short-term conse-
quence of laser resurfacing and subsides with time, especially with Er:YAG lasers.29 In all
experiments, TEWL rates were highest at PS07 and decreased by PS14. A previous pilot
study indicated that barrier function is severely disrupted in ventral pig skin by 3 to 7 days
afterexposuretoliquidHDfor30or120minutesanddoesnotreturntobaselinevaluesuntil
63 to 70 days postexposure (J.S.G., unpublished data, 1998). Barrier function principally
resides in the stratum corneum. In adult human skin, keratinocytes take approximately 2 to
4w eekstomigratefromthestratumbasaletothestratumgranulosumand2weekstotransit
the stratum corneum.35 It can thus take 4 to 6 weeks following initial wound coverage (thin
confluent layer of keratinocytes) for complete stratification to occur and a disrupted barrier
function to return to normal. It is not surprising that barrier function had not yet returned to
baseline levels in these pig wounds 14 to 21 days following debridement, especially those
sites debrided well into the upper reticular dermis. Nonetheless, signs of barrier repair were
noted (eg, decreasing TEWL rates).
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Er:YAG lasers have been used for a wide variety of procedures, ranging from facial
resurfacing to burn debridement.29,36−40 They have been shown to be particularly useful
in the debridement of partial-thickness burns40 and in the management of deep Lewisite
injuries.36 Unlike the Gaussian beam profiles created by CO2 lasers, Er:YAG laser beams
tend to be uniform and produce uniform depths of ablation.40
Biopsies were not collected during surgery to verify that the injuries were partial
thickness.An8-minuteexposuretoliquidHDwaspreviouslyshowntoconsistentlyproduce
superficial dermal HD injuries in weanling swine by 48 hours postexposure (F. M. Reid, J.
S. Graham, et al, unpublished data, 2004). Histopathological examination of skin samples
collected at the end of each study showed the presence of normal hair follicles, glands,
and smooth muscles. In addition, hair growth in the lesion areas was noted, and wound
contraction after laser debridement absent. These results indicated the HD injuries were not
deep-dermal or full-thickness.
These wound healing studies have demonstrated that with appropriate treatment, the
healingofcutaneousHDinjuriescanbeimproved.Studiesinprogressarecurrentlyevaluat-
ing enzymatic and chemical debridement agents as well as a commercially available hydro-
surgery system as alternatives to laser debridement. Upcoming wound healing experiments
will examine the effect of less aggressive laser debridement (eg, to a depth of 100 µm),
and the efficacy of skin substitutes, matrix metalloprotease-binding dressings, silver-ion
delivering dressings, topical nutritional support, keratinocyte sprays, and vacuum-assisted
closure. Screening a variety of debridement protocols and treatment adjuncts is crucial in
determining the most efficacious treatment regimen to be applied in the clinical manage-
ment of HD casualties. Improved treatment will speed the rate of wound closure, result in
a better cosmetic and functional outcome for the patient, and will enable the casualty to
return to normal activities sooner.
CONCLUSIONS
The conclusions of the study can be listed as follows:
 Within the first week of surgery, the neoepidermis appears to be very fragile and easily
removed. Care must be taken during bandage changes, and a nonadherent dressing that
could be left in place for a longer period of time (eg, 7 days) would be beneficial, both to
the patient and medical logistical burden (eg, nursing care).
 The use of cultured epithelial allograft material may have a potential role in the treatment
of debrided cutaneous HD injuries if grown on a completely nonadherent backing and
left undisturbed for at least a week.
 Following laser debridement, Xeroform Petrolatum and Scarlet Red Ointment dressings
are effective and inexpensive dressings for treatment of cutaneous HD injury. Reepithe-
lialization was nearly complete by 7 days postsurgery for many of the debrided sites
treated with these dressings.
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